Specifically, TAK1 expression has been observed in the synovial tissues of OA and rheumatoid arthritis (RA) patients [14], and TAK1 knockdown in rheumatoid arthritis-affected synoviocytes reduced matrix metalloproteinase-3 (MMP-3) expression by IL-1β [15]. This evidence concerns the gene MMP3 and rheumatoid arthritis.